Galapagos NV
GLPG
#4540
Rank
C$3.03 B
Marketcap
C$46.12
Share price
-0.73%
Change (1 day)
36.25%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: C$3.03 Billion

As of February 2026 Galapagos NV has a market cap of C$3.03 Billion. This makes Galapagos NV the world's 4540th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026C$3.03 B1.96%
2025C$2.98 B15.47%
2024C$2.58 B-27.34%
2023C$3.55 B-10.39%
2022C$3.96 B-14.84%
2021C$4.65 B-43.61%
2020C$8.25 B-53.21%
2019C$17.64 B158.07%
2018C$6.83 B13.23%
2017C$6.03 B50.78%
2016C$4.00 B17.11%
2015C$3.41 B416.31%
2014C$0.66 B-0.73%
2013C$0.66 B18.72%
2012C$0.56 B54.89%
2011C$0.36 B-14.68%
2010C$0.42 B58.56%
2009C$0.26 B114.65%
2008C$0.12 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Galapagos NV was reported to be:

C$3.03 Billion
by Nasdaq info icon info icon
C$3.03 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
C$745.32 B 24,423.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$258.96 B 8,420.68%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$536.54 B 17,554.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$155.53 B 5,017.59%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$374.94 B 12,236.80%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$391.56 B 12,783.66%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$141.96 B 4,571.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
C$0.13 B-95.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$53.22 B 1,651.30%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel